The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

A report on energy transition investments from BloombergNEF showed that global investment in clean energy technologies hit a ...

Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...

IPO content provided by Renaissance Capital LLC, manager of the IPO-focused ETFs (tickers: IPO, IPOs).

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

What Budget 2025 can do to power India's GCC surge Budget 2025: Global Capability Centers (GCCs) have evolved into significant contributors to India's GDP. The upcoming Budget might play a crucial ...

Rights Sep 13, 2024 Sep 13, 2024 Apr 23, 2024 Rights ratio: 1 share for every 1 held at a price of Rs 2.2 Rights Feb 17, 2022 Feb 18, 2022 Dec 01, 2021 Rights ratio: 3 share for every 4 held at a ...

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China ...